Trial intelligence / Profile preview

Genome-wide DNA pooling study of clopidogrel response after PCI

ChiCTR-OCH-11001198Phase 4Completed

Sponsor
Guangdong Provincial People's Hospital
Start
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of clopidogrel in coronary arteriosclerosis, sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Major adverse cardiac events. Started Jan 2011; status: completed.

02

Drugs

clopidogrel
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on ChiCTR-OCH-11001198.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OCH-11001198.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call